Department of Clinical Chemistry and Hematology, Zuyderland Medical Center, Heerlen & Sittard, The Netherlands.
Department of Internal Medicine, Zuyderland Medical Center, Heerlen & Sittard, The Netherlands.
Clin Chem Lab Med. 2020 Dec 9;59(4):783-793. doi: 10.1515/cclm-2020-1529. Print 2021 Mar 26.
COVID-19 is an ongoing global pandemic. There is an urgent need for identification and understanding of clinical and laboratory parameters related to progression towards a severe and fatal form of this illness, often preceded by a so-called cytokine-storm syndrome (CSS). Therefore, we explored the hemocytometric characteristics of COVID-19 patients in relation to the deteriorating clinical condition CSS, using the Sysmex XN-10 hematology analyzer.
From March 1st till May 16th, 2020, all patients admitted to our hospital with respiratory complaints and suspected for COVID-19 were included (n=1,140 of whom n=533 COVID-19 positive). The hemocytometric parameters of immunocompetent cells in peripheral blood (neutrophils [NE], lymphocytes [LY] and monocytes [MO]) obtained upon admission to the emergency department (ED) of COVID-19 positive patients were compared with those of the COVID-19 negative ones. Moreover, patients with CSS (n=169) were compared with COVID-19 positive patients without CSS, as well as with COVID-19 negative ones.
In addition to a significant reduction in leukocytes, thrombocytes and absolute neutrophils, it appeared that lymphocytes-forward scatter (LY-FSC), and reactive lymphocytes (RE-LYMPHO)/leukocytes were higher in COVID-19-positive than negative patients. At the moment of presentation, COVID-19 positive patients with CSS had different neutrophils-side fluorescence (NE-SFL), neutrophils-forward scatter (NE-FSC), LY-FSC, RE-LYMPHO/lymphocytes, antibody-synthesizing (AS)-LYMPHOs, high fluorescence lymphocytes (HFLC), MO-SSC, MO-SFL, and Reactive (RE)-MONOs. Finally, absolute eosinophils, basophils, lymphocytes, monocytes and MO-FSC were lower in patients with CSS.
Hemocytometric parameters indicative of changes in immunocompetent peripheral blood cells and measured at admission to the ED were associated with COVID-19 with and without CSS.
COVID-19 是一种持续的全球大流行疾病。目前迫切需要识别和了解与这种疾病向严重和致命形式发展相关的临床和实验室参数,这种疾病通常以前称为细胞因子风暴综合征(CSS)。因此,我们使用 Sysmex XN-10 血液分析仪探索了 COVID-19 患者与不断恶化的 CSS 临床状况相关的血液细胞特征。
从 2020 年 3 月 1 日至 5 月 16 日,我们纳入了所有因呼吸道症状并疑似 COVID-19 而入院的患者(共 1140 例,其中 533 例 COVID-19 阳性)。我们比较了急诊科入院时 COVID-19 阳性患者外周血免疫细胞的血液细胞参数(中性粒细胞[NE]、淋巴细胞[LY]和单核细胞[MO])与 COVID-19 阴性患者的参数。此外,我们比较了 CSS 患者(n=169)与 COVID-19 无 CSS 阳性患者以及 COVID-19 阴性患者的参数。
除白细胞、血小板和绝对中性粒细胞显著减少外,与 COVID-19 阴性患者相比,COVID-19 阳性患者的淋巴细胞前向散射(LY-FSC)和反应性淋巴细胞(RE-LYMPHO)/白细胞更高。在发病时,COVID-19 阳性伴有 CSS 的患者的中性粒细胞侧荧光(NE-SFL)、中性粒细胞前向散射(NE-FSC)、LY-FSC、RE-LYMPHO/淋巴细胞、抗体合成(AS)-LYMPHOs、高荧光淋巴细胞(HFLC)、单核细胞-SSC、单核细胞-SFL 和反应性(RE)-MONOs 不同。最后,CSS 患者的绝对嗜酸性粒细胞、嗜碱性粒细胞、淋巴细胞、单核细胞和 MO-FSC 较低。
入院时测量的提示外周血免疫细胞变化的血液细胞参数与 COVID-19 伴或不伴 CSS 相关。